In 2014, Tumeh, Paul C. published a fifth co-cited study in Nature (38), which showed that pre-existing CD8 T-cells distinctly located at the invasive tumor margin are associated with expression of the PD-1/PD-L1 immune inhibitory axis and may predict response to therapy. Here, CD274 is linked to neoplasm.